16:42 , Sep 7, 2018 |  BC Week In Review  |  Financial News

Qiming, Hillhouse lead Jacobio's $55M series C

Cancer company Beijing Jacobio Pharmaceutical Co. Ltd. (Beijing, China) raised $55 million in a series C round led by Qiming Venture Capital and Hillhouse Capital. Prudence Investment Management also participated. Jacobio's lead candidate JAB-3068, a...
23:58 , Sep 6, 2018 |  BioCentury  |  Finance

Jacobio’s ladder

Beijing Jacobio Pharmaceutical Co. Ltd. plans to use its $55 million series C round to fuel its creation of spinouts housing internally developed assets. Existing investor Qiming Venture Partners led the tranched round, which closed...
13:57 , Aug 31, 2018 |  BC Extra  |  Financial News

Qiming, Hillhouse lead Jacobio's $55M series C

Cancer company Beijing Jacobio Pharmaceutical Co. Ltd. (Beijing, China) raised $55 million in a series C round led by Qiming Venture Capital and Hillhouse Capital. Prudence Investment Management also participated. Jacobio's lead candidate JAB-3068, a...